PubRank

S Stefoni

Author PubWeight™ 47.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Kidney Donor Profile Index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes. Am J Transplant 2014 1.80
2 Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001 1.51
3 Benefits of early initiation of dialysis. Kidney Int Suppl 1985 1.12
4 [When native arteriovenous fistula is not possible: the permanent catheter is better]. G Ital Nefrol 2009 1.07
5 Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report. Br J Clin Pharmacol 1981 1.05
6 Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. Am J Transplant 2009 1.02
7 Long-term patient and renal prognosis in acute renal failure. Nephron 1984 0.98
8 Residual renal function and effective rehabilitation in chronic dialysis. Nephron 1976 0.97
9 Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 1998 0.93
10 Early dialysis in renal substitutive programs. Kidney Int Suppl 1978 0.92
11 Early dialysis and renal transplantation. Nephron 1986 0.91
12 Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant 2001 0.90
13 Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access 2006 0.90
14 Osteoporosis and urolithiasis. Urol Int 2004 0.89
15 The desorption process of macromolecules adsorbed on interfaces: the force spectroscopy approach. Chemphyschem 2001 0.88
16 [Determination in urine of the enzyme, gamma glutamyltranspeptidase (gamma GT). Usefulness in nephrology]. Minerva Nefrol 1980 0.88
17 An algorithm for the rational choice of sodium profile during hemodialysis. Int J Artif Organs 1997 0.86
18 Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug. Clin Nephrol 1982 0.85
19 Metabolic syndrome after kidney transplantation. Transplant Proc 2007 0.84
20 Predictive factors in chronic allograft nephropathy. Transplant Proc 2005 0.83
21 Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers. J Endocrinol Invest 2005 0.83
22 Clinical application of sodium profiling in the treatment of intradialytic hypotension. Int J Artif Organs 2003 0.83
23 Analysis of 80 dual-kidney transplantations: a multicenter experience. Transplant Proc 2011 0.83
24 Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach. Int J Artif Organs 2007 0.83
25 Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. Aliment Pharmacol Ther 2007 0.82
26 The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience. Transplant Proc 2010 0.82
27 The fatty acids of myelin phospholipids. FEBS Lett 1970 0.81
28 The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation 1997 0.81
29 A simple mathematical model of intradialytic sodium kinetics: "in vivo" validation during hemodialysis with constant or variable sodium. Int J Artif Organs 1996 0.80
30 Nephrological indications in combined liver-kidney transplantation. Transplant Proc 2006 0.80
31 Interaction between sphingomyelin and DNA. Biochim Biophys Acta 1972 0.80
32 A mathematical model for the prediction of solute kinetics, osmolarity and fluid volume changes during hemodiafiltration with on-line regeneration of ultrafiltrate (HFR). Int J Artif Organs 2006 0.80
33 Comparative cost/benefit analysis in early and late dialysis. Nephron 1983 0.80
34 Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetes Care 1987 0.80
35 Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report. Transplant Proc 2006 0.79
36 Evaluation of intradialytic solute and fluid kinetics. Setting Up a predictive mathematical model. Blood Purif 2000 0.79
37 De novo malignancies after organ transplantation. Transplant Proc 2001 0.79
38 Kidney transplantation combined with other organs in Bologna: an update. Transplant Proc 2008 0.79
39 A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine. Transplant Proc 2005 0.79
40 Family recurrence and oligo-anuria predict uremic restless legs syndrome. Acta Neurol Scand 2011 0.78
41 Lamivudine in recurrent hepatitis B after renal transplantation. Transplant Proc 2001 0.78
42 Crossmatch testing in renal transplantation: comparative evaluation between an innovatory ELISA technique and two different standardised CDC methods. Transplant Proc 1997 0.78
43 Immunologic changes in circulating leukocytes in the presence of atherosclerotic disease. Recenti Prog Med 1994 0.78
44 Short-term thoracic duct drainage in drug resistant immunologically mediated glomerulonephritis. Evaluation of lymph and blood lymphocyte characteristics during drainage. Clin Nephrol 1981 0.78
45 Combined liver-kidney transplantation: the experience of the University of Bologna and the case of preoperative positive cross-match. Transplant Proc 2006 0.77
46 Opinions on renal transplantation and organ donation in high school students in two large northern (Torino) and southern (Napoli) Italian cities. Transplant Proc 2004 0.77
47 Effects of dialysis membrane nature on intradialytic phagocytizing activity. Int J Artif Organs 1999 0.77
48 Native kidney function after renal transplantation combined with other solid organs in preemptive patients. Transplant Proc 2010 0.77
49 The cardiovascular burden of end-stage renal disease patients. Minerva Urol Nefrol 2010 0.77
50 ELISA anti-HLA antibody screening identifies non-complement-fixing antibodies responsible for acute graft rejection. A case report. Eur J Immunogenet 1996 0.77
51 Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience. Transpl Int 2000 0.77
52 Increased expression of P21((WAF1/CIP1)) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes. Transplant Proc 2003 0.77
53 Does bone mineral density predict fractures comparably in women and men? J Endocrinol Invest 2005 0.77
54 Kidney function after improved metabolic control in newly diagnosed diabetes and in diabetic patients with nephropathy. Diabetes Care 1987 0.76
55 Incidence of cancer in kidney transplantation waiting list patients: a single center experience. Transplant Proc 2011 0.76
56 Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc 2008 0.76
57 Renal transplant in patients with polycystic disease: the Italian experience. Transplant Proc 2013 0.76
58 [Malignant neoplasia and kidney transplantation. Retrospective analysis of data on the population having kidney transplantation with de novo neoplasia in the setting of the AIRT]. G Ital Nefrol 2004 0.76
59 Value of plasma exchange in renal transplant rejection induced by specific anti-HLA antibodies. Trans Am Soc Artif Intern Organs 1982 0.76
60 Tacrolimus-associated myositis: a case report in a renal transplant patient. Transplant Proc 2004 0.75
61 Effects of renal substitutive programs on amino acid patterns in chronic uremia. Kidney Int Suppl 1983 0.75
62 Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia. Contrib Nephrol 1982 0.75
63 Dynamic of a plasma microprotein (lysozyme) in uremic patients on hemodialytic treatment with different membranes. Life Support Syst 1985 0.75
64 Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results. Int J Artif Organs 1986 0.75
65 [Clinical evaluation of living donor]. G Ital Nefrol 2009 0.75
66 Evidence of profiled hemodialysis efficacy in the treatment of intradialytic hypotension. Int J Artif Organs 1998 0.75
67 Panel conference. Adsorbent hemoperfusion for blood purification. Trans Am Soc Artif Intern Organs 1980 0.75
68 Mismatch-specific anti-HLA antibody production following aorta transplants. Transpl Int 1998 0.75
69 [Evaluation of some biochemical characteristics in the lymph cell population in thoracic duct fistula]. G Clin Med 1972 0.75
70 Kidney transplantation combined with other organs: experience of Bologna s. Orsola hospital. Transplant Proc 2005 0.75
71 Strategies in renal failure and the impact of lipids. Int J Artif Organs 1993 0.75
72 [Current status of substitutive therapy with artificial means in chronic renal insufficiency: hemoperfusion and hemofiltration]. G Clin Med 1981 0.75
73 Present status of hemoperfusion/hemodialysis in Italy. Appl Biochem Biotechnol 1984 0.75
74 Double kidney transplantation: initial experience of the Bologna Transplant Center. Int J Artif Organs 2006 0.75
75 Investigations on the developing chicken bursa of fabricius. Poult Sci 1971 0.75
76 Effect of plasma exchange and thoracic duct drainage on immunological status in glomerulonephritis. Proc Eur Dial Transplant Assoc 1981 0.75
77 Physical performance in kidney transplanted patients: a study on desert trekking. J Biol Regul Homeost Agents 2011 0.75
78 Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia. Int J Artif Organs 1981 0.75
79 Donor-specific anti-HLA antibodies after bone-graft transplantation. Impact on a subsequent renal transplantation: a case report. Transplant Proc 2009 0.75
80 Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice. Transplant Proc 2002 0.75
81 A case of Paget's disease in hemodialysis. Clin Nephrol 2010 0.75
82 Combined liver-kidney transplantation--S. Orsola experience: nephrological aspects. Transplant Proc 2006 0.75
83 Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996 0.75
84 [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs]. G Ital Nefrol 2009 0.75
85 [The kidney during shock. Hemodynamic, biohumoral and ultrastructural changes]. Minerva Anestesiol 1982 0.75
86 Treatment of uremic patients with biofiltration: efficacy, biocompatibility and medium-term results. Int J Artif Organs 1986 0.75
87 The new bionic era in renal replacement therapy. Contrib Nephrol 1993 0.75
88 Multiple varieties of bionic support in kidney transplantation. Artif Organs 1992 0.75
89 Long term clinical and morphological evaluation of acute renal failure. Adv Exp Med Biol 1987 0.75
90 A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities. Nephrol Dial Transplant 1997 0.75
91 Evaluation of a new coated charcoal for hemoperfusion in uremia. Int J Artif Organs 1979 0.75
92 Renal transplantation and HCV hepatitis: a longitudinal study. Transplant Proc 2001 0.75
93 Regular hemoperfusion in regular dialysis treatment. A long-term study. Int J Artif Organs 1980 0.75
94 PDGF-AB release during and after haemodialysis procedure. Nephrol Dial Transplant 1999 0.75
95 Analysis of cell components extracted from immunocompetent organs of the chicken. Poult Sci 1973 0.75
96 Hormonal changes in uremia. Clin Nephrol 1979 0.75
97 Prolactin, zinc and sexual activity in dialysis patients. Proc Eur Dial Transplant Assoc 1979 0.75
98 Value of panel reactive antibodies (PRA) as a guide to the treatment of hyperimmunized patients in renal transplantation. Transpl Int 1992 0.75
99 [HCV+ patients on the waiting list for kidney transplantation. Retrospective analysis of data on the patient population with hepatitis C on the waiting list for kidney transplantation in the setting of the AIRT]. G Ital Nefrol 2004 0.75
100 A simple mathematical model applied to selection of the sodium profile during profiled haemodialysis. Nephrol Dial Transplant 1998 0.75
101 [Thoracic duct fistula in the therapy of immunological glomerular nephropathy. Time-related changes in cellular immunity]. Minerva Nefrol 1981 0.75
102 [The kidney in shock. Changes of some hemodynamic and bio-humoral parameters. II]. Boll Soc Ital Biol Sper 1981 0.75
103 Severe hypertension in chronic renal failure treated with minoxidil. Clin Exp Hypertens 1979 0.75
104 [Use of a caloric integrator in renal insufficiency]. G Clin Med 1978 0.75
105 [Characterization of the ribosomes of bladder tumors. Preliminary note]. Boll Soc Ital Biol Sper 1971 0.75
106 Immunosuppression in renal transplantation. Int J Artif Organs 1997 0.75
107 Fluidodynamic evaluation of arteriovenous fistulae for hemodialysis. J Vasc Access 2007 0.75
108 Mechanical effects of heart pulse propagation on a vessel-graft suture line stress. Int J Artif Organs 1998 0.75
109 Atherosclerosis in uremia: a longitudinal study. Am J Clin Nutr 1980 0.75
110 [Use of antilymphocyte globulin in glomerular nephropathies in adults]. G Clin Med 1972 0.75
111 Thymus and bursal ribosomes in the developing chicken. Poult Sci 1972 0.75
112 Posttraumatic chyluria due to lymphorenal fistula regressed after somatostatin therapy. Nephron 1996 0.75
113 [Renal transplantation in Bologna]. Minerva Chir 1980 0.75
114 Bionics in renal replacement therapy. Artif Organs 1993 0.75
115 Epidemiology of hepatitis C in a population of hemodialysis patients. Nephron 1992 0.75
116 Use of defibrotide in renal transplantation in man. Haemostasis 1986 0.75
117 Expression of activation antigens and adhesion molecules on mononuclear cells after short contact with materials for intraocular lenses. J Appl Biomater Biomech 2010 0.75
118 The role of renal biopsy in the diagnosis of Fabry's disease. Contrib Nephrol 2001 0.75
119 Severe unresponsive thrombocytopenia in a transplantated patient with chronic Werlhof's disease: correction after splenectomy. Nephron 1995 0.75
120 Hemoperfusion with a new anion exchange resin corrects the metabolic alkalosis in pyloric stenosis: an experimental demonstration. Int J Artif Organs 1992 0.75
121 Induction therapy with alemtuzumab (campath) in combined liver-kidney transplantation: University of Bologna experience. Transplant Proc 2013 0.75
122 Structure of dialysis membranes and long-term clinical outcome. Am J Nephrol 1995 0.75
123 Flow cytometry evaluation of urinary sediment in renal transplantation. Transpl Int 1992 0.75
124 Beta2-microglobulin and low-flux synthetic dialyzers. Artif Organs 1998 0.75
125 Survival and 'true' rehabilitation after dialysis and transplantation: a 7-year follow-up. Proc Eur Dial Transplant Assoc 1975 0.75
126 [Long-term use of Profiler in patients with dialysis intolerance: 8 months follow-up]. G Ital Nefrol 2005 0.75
127 Anticoagulation and platelet activation in hemodialysis: clinical results with PMMA. Contrib Nephrol 1999 0.75
128 Quantitative expression of T cell surface antigens in renal transplantation. Transplant Proc 1987 0.75
129 Bologna transplant center results in double kidney transplantation: update. Transplant Proc 2007 0.75
130 [Expression of metanephric differentiation markers in human mesenchymal stem cells]. G Ital Nefrol 2009 0.75
131 Kidney, patient and new millennium nephrology. Nephron 2000 0.75
132 [Protonic pump inhibitors in kidney transplant patients: efficacy and safety]. Minerva Urol Nefrol 2007 0.75
133 The clinical value of renal biopsy in transplantation. Transplant Proc 1979 0.75
134 [Chronic allograft dysfunction: role of immunosuppressive treatment]. G Ital Nefrol 2008 0.75
135 [Effects of antilymphocytic globulin on the histo-immunological lesions and on the clinical aspect of glomerular nephropathy in adults]. Minerva Nefrol 1974 0.75
136 Jugular vein-mammary artery fistula after catheterism for hemodialysis: case report. J Vasc Access 2007 0.75
137 [Research on ovarian lipids of oryctolagus cuniculus]. Quad Clin Ostet Ginecol 1969 0.75
138 [Improvement of impotence, taste and olfactory deficits in periodically hemodialyzed patients treated with zinc chloride]. Minerva Nefrol 1981 0.75
139 Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. Transplant Proc 2003 0.75
140 Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible? Transplant Proc 2008 0.75
141 Dialysis and transplant patients in the long term. Ann Ital Med Int 1993 0.75
142 Early dialysis. Contrib Nephrol 1984 0.75
143 Multicenter study on double kidney transplantation. Transplant Proc 2008 0.75
144 Incidence of late deep venous thrombosis among renal transplant patients. Transplant Proc 2013 0.75
145 Bionic artificial kidney. Artif Cells Blood Substit Immobil Biotechnol 1996 0.75
146 Artificial endocrine pancreas and diabetic nephropathy. Life Support Syst 1983 0.75
147 Fibroblast proliferation over dialysis membrane: an experimental model for "tissue" biocompatibility evaluation. Int J Artif Organs 1994 0.75
148 Platelet activation and PDGF-AB release during dialysis. Int J Artif Organs 2002 0.75
149 Evans syndrome in renal transplantation: correlation between drops in platelet and red blood cell counts and rejection. Nephron 1997 0.75
150 Severe gastrointestinal bleeding in a uremic patient treated with estrogen-progesterone therapy. Int J Artif Organs 1999 0.75
151 [Research on the biochemical eomiphene]. Boll Soc Ital Biol Sper 1971 0.75
152 Shortened treatment time by combined hemodialysis and hemoperfusion. Contrib Nephrol 1985 0.75
153 Better transmitral flow in hypertensives in comparison to normotensive patients with well functioning kidney transplant. Nephron 1996 0.75
154 [Double renal transplant. Retrospective analysis of data on the patient population with double kidney transplantation in the setting of the AIRT]. G Ital Nefrol 2004 0.75
155 Alpine skiing and anaerobic performance in solid organ transplant recipients. Transplant Proc 2010 0.75
156 Importance of renal mass on graft function outcome after 12 months of cadaveric donor kidney transplantation. Transplant Proc 2010 0.75
157 [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis]. G Clin Med 1981 0.75
158 Use of combined hemodialysis/hemoperfusion in chronic uremia. Contrib Nephrol 1982 0.75
159 Graft biopsy in renal transplantation: correlation with clinical, immunological, and virological investigations. Kidney Int Suppl 1983 0.75
160 [Guidelines for ambulatory monitoring of kidney transplant patients. Adaptation of the Guidelines of the American Society of Transplantation (J Am Soc Nephrol 2000; 11 (S1): 86)]. G Ital Nefrol 2005 0.75
161 Phosphate removal by resin hemoperfusion efficacy and biocompatibility of a new exchange resin. Biomater Artif Cells Immobilization Biotechnol 1992 0.75
162 A very early and acute renal impairment due to polyomavirus allograft nephropathy. Transpl Infect Dis 2010 0.75
163 [Value of the determination of alkaline phosphatase isoenzymes in patients undergoing periodic hemodialytic treatment]. Minerva Nefrol 1979 0.75
164 [Low-toxicity immunosuppressive therapy in renal transplant]. G Ital Nefrol 2007 0.75
165 [Factors determining cardiovascular disease progression after kidney transplant]. G Ital Nefrol 2009 0.75
166 Images in nephrology. Fibromuscular dysplasia in a transplanted kidney. Nephrol Dial Transplant 1998 0.75
167 Polymorphonucleates activity in dialysis patients treated with different membranes. Life Support Syst 1985 0.75
168 Mathematical modeling of solute kinetics and body fluid changes during profiled hemodialysis. Int J Artif Organs 1999 0.75
169 [Clinical value of various immunological diagnostic tests in nephrology]. G Clin Med 1981 0.75
170 [Recurrence of glomerulonephritis in transplanted kidney]. G Ital Nefrol 2003 0.75
171 [Therapy strategies in the prevention of chronic allograft nephropathy]. G Ital Nefrol 2005 0.75
172 Biocompatibility: a systems approach. Contrib Nephrol 1989 0.75
173 The first case of ureteral duplication in a combined liver-kidney transplantation. Int J Artif Organs 2006 0.75
174 Comparison of hemodialysis versus hemoperfusion in the clearance of high-dose methotrexate in pigs. Artif Organs 1995 0.75
175 Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia. Life Support Syst 1984 0.75
176 [Preliminary results of heterotransplants of fresh aortic valves of pigs]. Boll Soc Ital Biol Sper 1969 0.75
177 [Research on the biochemical evolution of the cerebellum during ontogenesis. II. Analysis of phospholipid fractions]. Boll Soc Ital Biol Sper 1971 0.75
178 Biocompatibility of charcoal hemoperfusion. Effects of long-term treatment on lymphocyte characteristics and function. Int J Artif Organs 1986 0.75
179 [Preventing and reducing comorbidity in candidates for kidney transplantation for the improvement of post-operative results]. G Ital Nefrol 2009 0.75
180 [Continuous ambulatory peritoneal dialysis (CAPD) in the substitutive treatment of chronic renal insufficiency]. G Clin Med 1981 0.75
181 [Histological and histochemical aspects of heterotransplants of pig aortic valves after preservation in formalin for 20 days]. Boll Soc Ital Biol Sper 1969 0.75
182 A real-time analysis of a transplantation program with a personal computer. MD Comput 1991 0.75
183 [Clinical significance of urinary enzyme loss after extracorporeal circulation. Enzymuria is a predictive index of early renal damage]. Minerva Anestesiol 1988 0.75